about
Anti-endothelial cell antibodies in systemic sclerosisAnticentromere antibody in primary biliary cirrhosis.Endothelial cell cytotoxicity in inflammatory vascular diseases--the possible role of oxidised lipoproteins.Plasma or serum from patients with systemic sclerosis alters behaviour of normal erythrocytes.Increased mitogenic activity of scleroderma serum: inhibitory effect of human recombinant interferon-gammaSafety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.Raynaud's phenomenon: its relevance to scleroderma.Clinical pharmacology, physiology and pathophysiology of superficial veins--2Systemic sclerosis: a prototypic multisystem fibrotic disorder.Clinical comments and a pathophysiological discussion of scleroderma.A brief overview of the pathogenesis of scleroderma (systemic sclerosis)Bronchioloalveolar carcinoma in progressive systemic sclerosisReplication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factorsBreast cancer and scleroderma.Acrosclerosis associated with vibration: an electron microscopic study.Retroperitoneal fibrosis and scleroderma.Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.The endothelium: its role in scleroderma.Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.A pathogenetic approach to the management of systemic sclerosis (scleroderma).Molecular and cellular basis of scleroderma.Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in FibrosisTissue plasminogen activator treatment of digital thrombosis in severe Raynaud's phenomenon--a case report.Pathogenesis of progressive systemic sclerosis.Immune response to connective tissue components of the basement membrane.Interaction of immune and connective tissue cells.The vascular endothelium in scleroderma.The role of the trimolecular complex (alpha beta TCR-MHC+peptide) in the pathogenesis of systemic sclerosis.Effect of heparin on pulmonary fibroblasts and vascular cells.Systemic sclerosis: a collagen or microvascular disease?Thrombospondin 1 in hypoxia-conditioned media blocks the growth of human microvascular endothelial cells and is increased in systemic sclerosis tissuesProtective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study.Value of finger arterial blood pressure in diagnosis of vascular changes in some connective tissue diseases.Successful long-term (22 year) treatment of limited scleroderma using therapeutic plasma exchange: Is blood rheology the key?Systemic sclerosis--a microvascular disorder?
P2860
Q33538934-B86EB4F8-778A-46BB-B131-A49163814503Q33553886-5C3597FD-D562-4204-B32C-83E67EADF86CQ33555753-4AFAC8DC-33C6-4C9B-ABF3-EA604A375FA5Q33555933-126DFEB2-6F2C-4DFD-A75E-19C9CBE6940CQ33566816-0F2018BE-B95A-46AF-A458-476F0617B28BQ33579356-3437E91C-D04E-4D4B-9A19-A0E3174984F3Q33631731-E151C71D-93ED-439B-9FAB-59C4884F0355Q34346189-E2DF6EC7-49BC-4D8D-8B47-046E93901767Q35649427-EC7AF996-A365-48B5-B3BB-9CC2DCD9D2CEQ35654907-A9C1798F-2540-4DBB-A2DE-3704CFE895D0Q35927432-51358198-0C1B-4464-B481-44CF7032A6B1Q35948265-DEFAAE2D-BD82-4FC8-AF9D-B77A7D539606Q36283386-4D27F1E9-83F7-4764-978B-B92F460F2ACDQ36416090-6CB9DD0E-8C4F-41A8-836B-1BC1E77494FDQ36668285-30067DA8-6209-4920-BAC6-C9B512861149Q36716521-CCAD43D2-A296-4192-942B-36605D79654FQ36721541-5A1F58E9-2241-4799-B238-5CAEB4FAAD7CQ36824550-3FD86F83-113B-4AD2-9BD6-3B7FBE4C2CBBQ37689681-A1696162-57C4-4D82-BEC2-DEC21F8E856FQ38021151-BCA41EB7-A87F-4FAA-AD05-A6293E0E254AQ38230276-22FAF011-E4F7-4CC9-B9C9-D68B0F5FEA37Q38542662-0FF4C637-98F3-4DDB-8A68-9AC5CA26EBF2Q39370856-1E2CA141-A1FD-407A-AADC-C6A5DC440B7BQ39407719-CAB1AC3D-9C2C-4CFA-9C64-46C3E383106BQ39736790-41F099FB-4702-4395-A215-F8DE0CA351ECQ40114202-CEC0E904-5549-4815-BA0F-9C310DBAF1B7Q40293144-F3B0C274-4C26-4C1B-AAF8-06885DBB7F36Q40468545-01036072-3A90-4B9F-AFBE-27F7205AC97FQ40468561-E830CC7F-9098-4F55-833A-8065F57AB6A1Q41147119-708D99B0-45F5-4863-92D1-2BB35E36F50CQ41984976-2EF079C3-0521-4F8D-AC13-76D35DC53F41Q42033229-DC310A49-194A-46DB-941F-05BBCA8CBD88Q42955705-AF9730AF-F526-42AC-AB9B-ABAD27665308Q46455274-DE292D3A-5597-49D3-89E4-C78089FE4DC4Q46519818-3226C4ED-7CF8-46E9-A9A0-EB220984B8B3Q55447984-5766D07C-4C58-43EF-9CAF-C3554C1DBCCF
P2860
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Endothelial injury in scleroderma
@ast
Endothelial injury in scleroderma
@en
type
label
Endothelial injury in scleroderma
@ast
Endothelial injury in scleroderma
@en
prefLabel
Endothelial injury in scleroderma
@ast
Endothelial injury in scleroderma
@en
P2093
P2860
P356
P1476
Endothelial injury in scleroderma
@en
P2093
P2860
P304
P356
10.1084/JEM.149.6.1326
P407
P577
1979-06-01T00:00:00Z